Celldex Therapeutics, Inc. (MM) News - CLDX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Celldex Therapeutics, Inc. (MM) CLDX NASDAQ Common Stock US15117B1035
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.05 -1.48% 3.33 3.42 3.31 3.39 3.38 14:24:01
more quote information »
Industry Sector

Recent News

Date Time Source Heading
2/14/201716:12EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
2/14/201716:04EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
2/14/201713:07EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201710:58EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201706:01EDGARNotice of Effectiveness (effect)
2/14/201706:01EDGARNotice of Effectiveness (effect)
2/13/201714:45GLOBECelldex Therapeutics Announces Upcoming Investor..
2/10/201709:42EDGARStatement of Ownership (sc 13g)
2/10/201708:09EDGARAmended Statement of Ownership (sc 13g/a)
2/10/201706:20EDGARAmended Statement of Ownership (sc 13g/a)
2/09/201716:03EDGARSecurities Registration Statement (simplified Form) (s-3/a)
2/09/201713:59EDGARAmended Statement of Ownership (sc 13g/a)
2/07/201716:04EDGARAmended Current Report Filing (8-k/a)
1/31/201710:48EDGARAmended Statement of Ownership (sc 13g/a)
1/26/201716:03EDGARSecurities Registration Statement (simplified Form) (s-3)
1/23/201714:23EDGARAmended Statement of Ownership (sc 13g/a)
12/15/201616:10EDGARStatement of Changes in Beneficial Ownership (4)
12/15/201616:09EDGARStatement of Changes in Beneficial Ownership (4)
12/15/201616:03EDGARInitial Statement of Beneficial Ownership (3)
12/14/201616:09EDGARCurrent Report Filing (8-k)
12/14/201616:01GLOBECelldex Therapeutics Announces Appointment to Board of..
12/09/201611:58EDGARStatement of Ownership (sc 13g)
12/05/201616:07EDGARInitial Statement of Beneficial Ownership (3)
12/05/201616:04EDGARCurrent Report Filing (8-k)
12/05/201616:01GLOBETheresa LaVallee, Ph.D., Joins Celldex Therapeutics’ Senior..
12/05/201608:01GLOBECelldex Presents Data on CDX-1140, a Novel CD40 Agonist..
12/02/201616:03EDGARSecurities Registration Statement (simplified Form) (s-3)
11/29/201616:47EDGARSmall Company Offering and Sale of Securities Without..
11/29/201616:05EDGARCurrent Report Filing (8-k)
11/29/201616:01GLOBECelldex Therapeutics Completes Acquisition of Kolltan..
11/14/201608:01GLOBECelldex Presents Data on New Product Candidate, CDX-1140, a..
11/07/201616:40EDGARQuarterly Report (10-q)
11/07/201616:07EDGARCurrent Report Filing (8-k)
11/07/201616:01GLOBECelldex Reports Third Quarter 2016 Results
11/01/201616:08EDGARCurrent Report Filing (8-k)
11/01/201616:02GLOBECelldex Expands Antibody and Immuno-Oncology Portfolio with..
10/09/201607:00GLOBEPhase 2 Study of Single-agent Glembatumumab Vedotin in..
9/23/201611:30GLOBECelldex Therapeutics to Present at the Leerink Partners Rare..
9/07/201613:00EDGARStatement of Changes in Beneficial Ownership (4)
9/06/201613:05EDGARStatement of Changes in Beneficial Ownership (4)
8/12/201607:59EDGARInitial Statement of Beneficial Ownership (3)
8/11/201608:04EDGARCurrent Report Filing (8-k)
8/11/201608:01GLOBECelldex Appoints Elizabeth Crowley as Chief Product..
8/08/201616:14EDGARQuarterly Report (10-q)
8/08/201616:02EDGARCurrent Report Filing (8-k)
8/08/201616:01GLOBECelldex Reports Second Quarter 2016 Results
8/02/201616:30GLOBECelldex to Report Second Quarter 2016 Financial Results and..
7/11/201616:01GLOBECelldex Therapeutics Initiates Phase 1/2 Clinical Trial of..
7/07/201616:01GLOBECelldex Therapeutics to Participate in the Cantor Fitzgerald..
6/09/201616:32EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.